JPMorgan Chase & Co. Boosts Envista (NYSE:NVST) Price Target to $29.00

Key Points

• JPMorgan raised its price target on Envista from $26 to $29 while maintaining a "neutral" rating, implying roughly an 18% upside from the current share price.
• Q1 beat: Envista reported $0.36 EPS versus $0.31 expected and $705.5M revenue (organic revenue up ~14%), and set FY‑2026 guidance of $1.35–$1.45 (midpoint ~1.40).
• Profitability and valuation concerns remain—net margin about 1.7% and a P/E near 87—contributing to a consensus "Hold" and an average analyst target of roughly $28.83.

Envista (NYSE:NVST - Get Free Report) had its target price boosted by JPMorgan Chase & Co. from $26.00 to $29.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has a "neutral" rating on the stock. JPMorgan Chase & Co.'s price objective would indicate a potential upside of 18.13% from the stock's current price.

Other analysts also recently issued reports about the company. Stifel Nicolaus set a $31.00 price target on Envista in a research note on Friday, February 6th. Barclays boosted their target price on Envista from $24.00 to $34.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 11th. Citigroup assumed coverage on Envista in a research report on Wednesday, April 15th. They set a "neutral" rating and a $29.00 target price on the stock. Weiss Ratings upgraded Envista from a "sell (d)" rating to a "hold (c-)" rating in a research report on Tuesday, February 17th. Finally, Morgan Stanley boosted their target price on Envista from $19.00 to $21.00 and gave the stock an "equal weight" rating in a research report on Friday, April 24th. Six analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Envista currently has a consensus rating of "Hold" and an average target price of $28.83.

Envista Price Performance

Shares of Envista stock traded down $2.52 during trading on Thursday, reaching $24.55. The company's stock had a trading volume of 9,194,392 shares, compared to its average volume of 2,815,126. The company has a quick ratio of 2.04, a current ratio of 2.38 and a debt-to-equity ratio of 0.47. Envista has a 12-month low of $16.41 and a 12-month high of $30.42. The company has a market capitalization of $4.00 billion, a P/E ratio of 87.18, a price-to-earnings-growth ratio of 1.79 and a beta of 0.92. The business has a 50 day moving average price of $26.63 and a 200-day moving average price of $24.03.

Envista (NYSE:NVST - Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share for the quarter, beating analysts' consensus estimates of $0.31 by $0.05. Envista had a return on equity of 6.54% and a net margin of 1.73%.The firm had revenue of $705.50 million for the quarter, compared to the consensus estimate of $680.04 million. During the same period in the previous year, the business earned $0.24 earnings per share. The company's revenue for the quarter was up 14.4% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, sell-side analysts anticipate that Envista will post 1.4 EPS for the current year.

Insider Buying and Selling at Envista

In other news, SVP Mischa Reis sold 9,675 shares of the business's stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total value of $290,250.00. Following the completion of the transaction, the senior vice president directly owned 32,382 shares of the company's stock, valued at $971,460. The trade was a 23.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.99% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Envista

Several institutional investors have recently added to or reduced their stakes in the business. Dimensional Fund Advisors LP increased its stake in Envista by 0.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 9,628,460 shares of the company's stock valued at $209,036,000 after purchasing an additional 90,586 shares during the last quarter. Alliancebernstein L.P. increased its stake in Envista by 34.0% during the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company's stock worth $119,164,000 after acquiring an additional 1,547,656 shares during the last quarter. Massachusetts Financial Services Co. MA increased its stake in Envista by 15.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 3,349,874 shares of the company's stock worth $72,726,000 after acquiring an additional 444,725 shares during the last quarter. Millennium Management LLC increased its stake in Envista by 1,442.7% during the fourth quarter. Millennium Management LLC now owns 2,420,615 shares of the company's stock worth $52,552,000 after acquiring an additional 2,263,712 shares during the last quarter. Finally, AQR Capital Management LLC increased its stake in Envista by 72.3% during the fourth quarter. AQR Capital Management LLC now owns 2,356,968 shares of the company's stock worth $51,170,000 after acquiring an additional 988,714 shares during the last quarter.

Key Envista News

Here are the key news stories impacting Envista this week:

• Positive Sentiment: Q1 beat — Envista delivered $0.36 EPS vs. $0.31 consensus and revenue of $705.5M vs. ~$680M, with organic revenue up ~14% year-over-year, showing broad-based strength. Envista Reports First Quarter 2026 Results
• Positive Sentiment: Analyst upgrade — Robert W. Baird raised its price target to $31 and kept an Outperform rating, signaling buy-side confidence in the company’s growth trajectory. Benzinga
• Positive Sentiment: Street commentary highlights new growth drivers and operating leverage potential that could expand margins if revenue momentum continues. Envista: Spotlight On Q1 Outperformance And New Growth Drivers
• Neutral Sentiment: FY‑2026 guidance set to $1.35–$1.45 EPS (midpoint ~1.40), essentially in line with consensus — helps visibility but doesn’t materially raise expectations. Envista FY2026 Guidance (Press Release/Slides)
• Neutral Sentiment: Earnings call and transcript provide color on geographic trends, product mix, and margin drivers — useful for judging sustainability of the beat. Q1 2026 Earnings Call Transcript
• Negative Sentiment: Profitability concerns — net margin remains low (~1.7%) and valuation is rich (high P/E), which could limit upside if margin expansion or guidance beats don’t materialize. Analysts and metric reviews flagged areas to monitor. Here's What Key Metrics Tell Us About Envista (NVST) Q1 Earnings

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company's offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista's product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.